Galena Biopharma (GALE) Issues Update to FBP-E39 Phase 1/2 at ASCO
Tweet Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced two publications at the American Society of Clinical Oncologists (ASCO) 2013 Annual Meeting taking place ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


